Eight companies are the latest to become one of the categories of membership, the Association of the British Pharmaceutical Industry (ABPI) has announced.
ABPI Head of Membership Services, Jeremy Way said: “We would like to welcome such a professional and diverse range of new members to the ABPI. The membership list has increased by 25 companies for 2007 which increases the depth of expertise available to members.”
The latest new members are:
Siemens plc – the number one global supplier of diagnostics solutions – based in Camberley, Surrey. Siemens Medical Solutions supplies high-technology imaging and diagnostics equipment, primarily to healthcare providers but also the pharmaceutical industry and to clinical research organisations.
Pharmacogenomic Innovative Solutions Ltd, (PGIX) of Maidenhead, Berkshire. The company specialises in applying expertise in pharmacogenomics in drug development, both in partnership with small/medium companies and by in-licensing compounds from discovery bioventures to develop in-house optimal applications of pharmacogenomics.
Covington and Burling LLP of Strand, London WC2 provides legal services to regulated industries, particularly the pharmaceutical sector.
Howrey LLP of London EC4 is a firm of solicitors with a focus on servicing the needs of Life Science companies in the fields of intellectual property, regulators and licensing.
Linklaters of Silk Street, London EC2, which advises pharmaceutical companies in intellectual property issues, especially patents and regulatory matters.
Lovells LLP of Holborn Viaduct, London EC1 is a global law firm providing business focused legal solutions to its clients across a wide range of industry sectors from 26 offices in Europe, Asia and the United States.
Patent Seekers of Celtic Lakes, Newport, Wales, offers its client base advice in patent searches including novelty, state of the art, infringement and validity in most technical areas.
Keats Healthcare of Burton-on-Trent, Staffordshire is involved in clinical trial procurement, sourcing comparator drugs and diagnostics on a global basis.
For further information, please contact: ABPI Press Office 020 7747 1410